{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:25:04Z","timestamp":1783095904754,"version":"3.54.6"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["24NSFSC0233"],"award-info":[{"award-number":["24NSFSC0233"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-026-04205-7","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:26:50Z","timestamp":1777998410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myectomy with secondary chordal resection in hypertrophic obstructive cardiomyopathy: the mid-term outcomes"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhuheng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zedong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changping","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"issue":"4","key":"4205_CR1","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jacc.2021.12.002","volume":"79","author":"BJ Maron","year":"2022","unstructured":"Maron BJ, Desai MY, Nishimura RA, et al. Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022;79(4):372\u201389.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"4205_CR2","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1016\/j.jacc.2020.08.044","volume":"76","author":"SR Ommen","year":"2020","unstructured":"Ommen SR, Mital S, Burke MA, et al. 2020 AHA\/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2020;76(25):3022\u201355.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"4205_CR3","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jacc.2021.11.021","volume":"79","author":"BJ Maron","year":"2022","unstructured":"Maron BJ, Desai MY, Nishimura RA, et al. Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022;79(4):390\u2013414.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"4205_CR4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/jamacardio.2022.0259","volume":"7","author":"M Zhou","year":"2022","unstructured":"Zhou M, Ta S, Hahn RT, et al. Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy. JAMA Cardiol. 2022;7(5):529\u201338.","journal-title":"JAMA Cardiol"},{"issue":"5","key":"4205_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jacc.2010.07.055","volume":"57","author":"T Lawrenz","year":"2011","unstructured":"Lawrenz T, Borchert B, Leuner C, et al. Endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy: acute results and 6 months\u2019 follow-up in 19 patients. J Am Coll Cardiol. 2011;57(5):572\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"4205_CR6","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/S0735-1097(00)00830-5","volume":"36","author":"MV Sherrid","year":"2000","unstructured":"Sherrid MV, Gunsburg DZ, Moldenhauer S, Pearle G. Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2000;36(4):1344\u201354.","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"4205_CR7","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/j.jacc.2014.04.090","volume":"64","author":"R Ro","year":"2014","unstructured":"Ro R, Halpern D, Sahn DJ, et al. Vector flow mapping in obstructive hypertrophic cardiomyopathy to assess the relationship of early systolic left ventricular flow and the mitral valve. J Am Coll Cardiol. 2014;64(19):1984\u201395.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"4205_CR8","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.jacc.2016.01.071","volume":"67","author":"MV Sherrid","year":"2016","unstructured":"Sherrid MV, Balaram S, Kim B, Axel L, Swistel DG. The Mitral Valve in Obstructive Hypertrophic Cardiomyopathy: A Test in Context. J Am Coll Cardiol. 2016;67(15):1846\u201358.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"4205_CR9","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1161\/01.CIR.85.5.1651","volume":"85","author":"HG Klues","year":"1992","unstructured":"Klues HG, Maron BJ, Dollar AL, Roberts WC. Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation. 1992;85(5):1651\u201360.","journal-title":"Circulation"},{"issue":"5","key":"4205_CR10","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.athoracsur.2008.07.048","volume":"86","author":"SK Balaram","year":"2008","unstructured":"Balaram SK, Tyrie L, Sherrid MV, et al. Resection-plication-release for hypertrophic cardiomyopathy: clinical and echocardiographic follow-up. Ann Thorac Surg. 2008;86(5):1539\u201345.","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"4205_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0735-1097(96)00103-9","volume":"28","author":"MJ Kofflard","year":"1996","unstructured":"Kofflard MJ, van Herwerden LA, Waldstein DJ, et al. Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 1996;28(1):197\u2013202.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"4205_CR12","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1111\/jocs.14919","volume":"35","author":"CJAK Marc Gillinov","year":"2020","unstructured":"Marc Gillinov CJAK, Smedira A, Hodges NG, Burns K, Wierup DJP. Robotic trans-mitral septal myectomy and papillary muscle reorientation for HOCM combined with or without mitral valve repair: Technical aspects - How we do it. J Card Surg. 2020;35(11):3120\u20134.","journal-title":"J Card Surg"},{"issue":"15","key":"4205_CR13","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.jacc.2015.07.069","volume":"66","author":"P Ferrazzi","year":"2015","unstructured":"Ferrazzi P, Spirito P, Iacovoni A, et al. Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy. J Am Coll Cardiol. 2015;66(15):1687\u201396.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"4205_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jtcvs.2020.12.143","volume":"165","author":"J Lentz Carvalho","year":"2023","unstructured":"Lentz Carvalho J, Schaff HV, Nishimura RA, et al. Is anterior mitral valve leaflet length important in outcome of septal myectomy for obstructive hypertrophic cardiomyopathy? J Thorac Cardiovasc Surg. 2023;165(1):79\u2013e871.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"4205_CR15","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/ejcts\/ezab116","volume":"60","author":"E Ram","year":"2021","unstructured":"Ram E, Schwammenthal E, Kuperstein R, et al. Secondary chordal resection with septal myectomy for treatment of symptomatic obstructive hypertrophic cardiomyopathy. Eur J Cardiothorac Surg. 2021;60(3):699\u2013707.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"11","key":"4205_CR16","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.3390\/jcm11113083","volume":"11","author":"LF Dorobantu","year":"2022","unstructured":"Dorobantu LF, Iosifescu TA, Ticulescu R, et al. Transaortic Shallow Septal Myectomy and Cutting of Secondary Fibrotic Mitral Valve Chordae-A 5-Year Single-Center Experience in the Treatment of Hypertrophic Obstructive Cardiomyopathy. J Clin Med. 2022;11(11):3083.","journal-title":"J Clin Med"},{"issue":"4","key":"4205_CR17","doi-asserted-by":"publisher","first-page":"318","DOI":"10.21037\/acs.2017.04.03","volume":"6","author":"D Hang","year":"2017","unstructured":"Hang D, Nguyen A, Schaff HV. Surgical treatment for hypertrophic cardiomyopathy: a historical perspective. Ann Cardiothorac Surg. 2017;6(4):318\u201328.","journal-title":"Ann Cardiothorac Surg"},{"issue":"5","key":"4205_CR18","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.athoracsur.2008.01.061","volume":"85","author":"RK Kaple","year":"2008","unstructured":"Kaple RK, Murphy RT, DiPaola LM, et al. Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. Ann Thorac Surg. 2008;85(5):1527\u2013e153515352.","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"4205_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.athoracsur.2005.01.064","volume":"80","author":"SK Balaram","year":"2005","unstructured":"Balaram SK, Sherrid MV, Derose JJ Jr, Hillel Z, Winson G, Swistel DG. Beyond extended myectomy for hypertrophic cardiomyopathy: the resection-plication-release (RPR) repair. Ann Thorac Surg. 2005;80(1):217\u201323.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"4205_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jtcvs.2009.10.045","volume":"140","author":"DH Kwon","year":"2010","unstructured":"Kwon DH, Smedira NG, Thamilarasan M, Lytle BW, Lever H, Desai MY. Characteristics and surgical outcomes of symptomatic patients with hypertrophic cardiomyopathy with abnormal papillary muscle morphology undergoing papillary muscle reorientation. J Thorac Cardiovasc Surg. 2010;140(2):317\u201324.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"19","key":"4205_CR21","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.108.796151","volume":"119","author":"AP Lee","year":"2009","unstructured":"Lee AP, Acker M, Kubo SH, et al. Mechanisms of recurrent functional mitral regurgitation after mitral valve repair in nonischemic dilated cardiomyopathy: importance of distal anterior leaflet tethering. Circulation. 2009;119(19):2606\u201314.","journal-title":"Circulation"},{"issue":"27","key":"4205_CR22","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/eurheartj\/ehz306","volume":"40","author":"AHJ Petrus","year":"2019","unstructured":"Petrus AHJ, Dekkers OM, Tops LF, Timmer E, Klautz RJM, Braun J. Impact of recurrent mitral regurgitation after mitral valve repair for functional mitral regurgitation: long-term analysis of competing outcomes. Eur Heart J. 2019;40(27):2206\u201314.","journal-title":"Eur Heart J"},{"issue":"14","key":"4205_CR23","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.jacc.2016.07.735","volume":"68","author":"JH Hong","year":"2016","unstructured":"Hong JH, Schaff HV, Nishimura RA, et al. Mitral Regurgitation in Patients With Hypertrophic Obstructive Cardiomyopathy: Implications for Concomitant Valve Procedures. J Am Coll Cardiol. 2016;68(14):1497\u2013504.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"4205_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/ejcts\/ezab097","volume":"60","author":"E Lapenna","year":"2021","unstructured":"Lapenna E, Nisi T, Carino D, et al. Hypertrophic cardiomyopathy with moderate septal thickness and mitral regurgitation: long-term surgical results. Eur J Cardiothorac Surg. 2021;60(2):244\u201351.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"11 Suppl 1","key":"4205_CR25","first-page":"II115","volume":"110","author":"F Rodriguez","year":"2004","unstructured":"Rodriguez F, Langer F, Harrington KB, et al. Importance of mitral valve second-order chordae for left ventricular geometry, wall thickening mechanics, and global systolic function. Circulation. 2004;110(11 Suppl 1):II115\u201322.","journal-title":"Circulation"},{"issue":"11 Suppl 1","key":"4205_CR26","first-page":"II91","volume":"110","author":"F Rodriguez","year":"2004","unstructured":"Rodriguez F, Langer F, Harrington KB, et al. Cutting second-order chords does not prevent acute ischemic mitral regurgitation. Circulation. 2004;110(11 Suppl 1):II91\u20137.","journal-title":"Circulation"},{"issue":"9","key":"4205_CR27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.31083\/j.rcm2409246","volume":"24","author":"Z Wu","year":"2023","unstructured":"Wu Z, Xie L, Li Y, Lin K, Zhang S, Qian H. Mitral Valve in Obstructive Hypertrophic Cardiomyopathy: Abnormalities, Management and Controversies. Rev Cardiovasc Med. 2023;24(9):246.","journal-title":"Rev Cardiovasc Med"},{"issue":"10253","key":"4205_CR28","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","volume":"396","author":"I Olivotto","year":"2020","unstructured":"Olivotto I, Oreziak A, Barriales-Villa R, et al. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2020;396(10253):759\u201369.","journal-title":"Lancet"},{"issue":"47","key":"4205_CR29","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1093\/eurheartj\/ehae579","volume":"45","author":"P Garcia-Pavia","year":"2024","unstructured":"Garcia-Pavia P, Or\u0119ziak A, Masri A, et al. Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy. Eur Heart J. 2024;45(47):5071\u201383.","journal-title":"Eur Heart J"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-026-04205-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04205-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04205-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:03:56Z","timestamp":1783094636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13019-026-04205-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4205"],"URL":"https:\/\/doi.org\/10.1186\/s13019-026-04205-7","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board [2023(2408)], and patients\u2019 consents were waived due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"467"}}